Showing results (231-240 of 291) with videos related to

Sort By:
Pageof 30
Biochemical Pharmacology|April 1, 1983
Inhibition of lymphocyte function by 9-deazaadenosineT P Zimmerman, R D Deeprose, G Wolberg, et al.
Cancer Research|December 15, 1994
Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assaysR S Israeli, W H Miller, S L Su, et al.
Leukemia|February 22, 2013
The novel arsenical Darinaparsin circumvents BRG1-dependent, HO-1-mediated cytoprotection in leukemic cellsN Garnier, L A Petruccelli, M F Molina, et al.
Antiviral Research|May 1, 1996
DNA polymerase activity of hepatitis B virus particles: differential inhibition by L-enantiomers of nucleotide analogsM G Davis, J E Wilson, N A VanDraanen, et al.
Cancer Research|December 1, 1995
Radiolabeled anti-CD33 monoclonal antibody M195 for myeloid leukemiasJ G Jurcic, P C Caron, T K Nikula, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 8, 2014
A phase I dose escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancerM Aglietta, C Barone, M B Sawyer, et al.
Veterinary Pathology|January 22, 2000
Feline papillomas and papillomavirusesJ P Sundberg, M Van Ranst, R Montali, et al.
Cancer Chemotherapy and Pharmacology|December 1, 2012
Phase I evaluation of the effects of ketoconazole and rifampicin on cediranib pharmacokinetics in patients with solid tumoursU Lassen, W H Miller, S Hotte, et al.
Bioorganic & Medicinal Chemistry|September 1, 1994
Design of a potent and orally active nonpeptide platelet fibrinogen receptor (GPIIb/IIIa) antagonistW E Bondinell, R M Keenan, W H Miller, et al.
Oncogene|June 27, 2012
The hedgehog processing pathway is required for NSCLC growth and survivalJ Rodriguez-Blanco, N S Schilling, R Tokhunts, et al.
Pageof 30